Nanotechnology: metastatic breast cancer and beyond.
Bruce
Susan D
SD
Duke Oncology Network, Durham, NC, USA.
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D002986:Clinical Trials as Topic; D004337:Drug Carriers / Q000627:therapeutic use; D004346:Drug Information Services; D005544:Forecasting; D006801:Humans; D020407:Internet; D049329:Nanostructures / Q000706:statistics & numerical data; D036103:Nanotechnology / Q000379:methods* / Q000639:trends; D009362:Neoplasm Metastasis; D024802:Nurse's Role; D009859:Oncology Nursing / Q000458:organization & administration; D015996:Survival Rate; D043823:Taxoids / Q000627:therapeutic use; D013673:Technology Assessment, Biomedical
D000972:Antineoplastic Agents, Phytogenic; D004337:Drug Carriers; D043823:Taxoids